Squeezed between sponsor expectations and Tier-1 budgets
Three numbers describe the position every mid-size CRO and FSP is in right now — and why standing still is the expensive option.
Talent you can't hire
of life-sciences employers can't find the skilled talent they need — the most talent-scarce industry measured. The people you need most are the hardest to buy.
Tier-1s are spending it on AI
Tier-1 CROs are investing heavily in agentic AI platforms to win sponsor trust. Mid-size CROs and FSPs need the same governance credibility, without the same balance sheet.
The AI gap is not the model
of life-sciences leaders have scaled AI. What stalls the rest is governance, validation, and people who can run both — exactly what we build.
Modernize. Credential. Extend. Co-deliver.
Modernize your operations
A structured, five-phase modernization sequence — assess, architect, connect, automate, evolve — built by the team that architected the unified eClinical platform behind 1,000+ trials. Fixed-fee assessment first; nothing speculative.
Credential your people
Novel-therapy safety training — CAR-T, ADC, cell & gene — governed-AI fluency, and role-based credentialing across clinical operations, so your staff commands premium work instead of competing on rate. Delivered with the AyurDatta Academy.
Extend what you can sell
Sponsor-facing capability — specialist safety services, real-time trial visibility, AI-governance assurance — delivered under your brand and powered quietly by ours. Built for resale from day one.
Co-deliver on your bids
Named, board-certified medical and safety experts on your bid team for CAR-T, ADC, and other novel-modality work — staying on the study when you win. Your sponsor sees your brand; your team gains the depth.
One fixes the cost side. One builds your bench. One builds the revenue side. One wins the bid. Most firms need more than one — but every engagement starts with exactly one.
How we plug into your bids
Capability positioning
We help you position named medical and safety depth in the RFP response — before the bid is even scored.
Bid defense
Our named expert joins the sponsor defense meeting alongside your team — answering the clinical and safety questions directly.
Delivery
If you win, the same named expert stays on the study — not a bait-and-switch to a different reviewer post-award.
Sponsor audit & qualification
A credential dossier ready when the sponsor's QA or auditor asks who reviewed the work and why they're qualified.
A three-layer delivery model
You run operations
Your CRO or FSP owns the client relationship, the SOW, and day-to-day trial execution — unchanged.
Execution partners deliver specialist functions
Your existing subcontractors and specialist vendors continue delivering the functions they already own.
AyurDatta provides medical, safety & AI governance
We supply the named physician judgment and AI-governance layer sponsors are increasingly asking every bidder to prove.
Considering a Qualified Research Institution role?
HHS's proposed Expedited IND pilot envisions CROs and medical centers pre-reviewing Phase 1 protocols. That role needs on-demand, physician-level protocol and IND review capacity most CROs don't carry in-house today — exactly the capability we provide.
Your brand leads. We power it quietly.
Your sponsors see your name on the dashboard, the report, and the service line. We take a “powered by” mark — or none at all — your call. And we put the commitment that matters in writing:
- ▶ We do not compete for your sponsors' full-service work
- ▶ One accountable partner — not five subcontractors
- ▶ Every deliverable stays with your team, whoever advises you next
- ▶ Your team fields sponsor questions with our support — not the other way around
"AyurDatta is the engine, not the storefront."
The ingredient-brand model — your sponsors buy from you; we make what you sell stronger.
Built and operated at the scale you're building toward
clinical trials run on the unified eClinical platform our principal architected — built from the operations side, not a vendor's slide deck.
Technology and architecture on one side; clinical development, pharmacovigilance, and regulatory strategy on the other. Every engagement draws on both.
of drug approvals supported over time — inside FDA-regulated environments, not around them.
Educate · Evaluate · Execute — for CROs
Sales enablement & Academy credentialing
Novel-therapy safety training and governed-AI fluency for your BD and delivery teams, via the AyurDatta Academy — so your team can sell and defend the capability, not just describe it.
Maturity assessment or AI assurance gap
A bounded, fixed-fee assessment across five maturity dimensions — data architecture, interoperability, AI readiness, governance, future-readiness. You own the report outright.
Weeks · fixed fee
Co-delivery, white-label IHASG, modernization lighthouse
One bounded, governed use case first — one modality, one workflow, one service, measured before anything scales. Then extend across modalities and functions, harden governance into your SOPs, and support sponsor qualifications — on a retainer scaled to activity.
Bounded scope, then ongoing retainer
Nothing here is a quote until we've mapped your maturity together.
Questions CROs ask us
Do you compete for our sponsors?
No. We don't pursue your sponsors' full-service work — that commitment is in writing, not a verbal assurance.
How does white-label work?
Your sponsors see your name on the dashboard, the report, and the service line. We take a "powered by" mark, or none at all — your call.
How is liability handled?
Scoped explicitly in the SOW for each engagement — named responsibilities by layer, so it's clear who is accountable for what before work begins.
How are you paid?
Fixed-fee for assessments and bounded engagements, a retainer once you scale, or a deal-scoped arrangement for bid co-delivery — see Commercial Models.
Where does your organization actually stand?
A confidential working session against the five maturity dimensions — no scoring pressure, no pitch. Just an honest map and one realistic quick win.
Book a working session